Large Deal Wins at $3.8 Billion with 55% Net New; Demonstrating Deep Competitive Advantage in Consolidation Play ...

Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting ...

- Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in patients with KRASG12D-mutant pancreatic, colorectal, and ...

Avel eCare, a leading provider of telemedicine services in the United States, today announced the appointment of Martainn Lenhardt as Chief Financial Officer (CFO). Lenhardt brings over 20 years of ...

Q2 2025 Earnings Call Transcript July 22, 2025 Operator: Greetings. Welcome to Valmont Industries, Inc. Second Quarter 2025 ...

Q2 2025 Earnings Call Transcript July 22, 2025 Tenet Healthcare Corporation beats earnings expectations. Reported EPS is ...